Histotripsy Systems Market Key Trends and Growth Forecast Through 2034

Histotripsy is an innovative ultrasound-based therapy that utilizes acoustic cavitation to mechanically destroy targeted tissues. Unlike traditional thermal ablation methods, histotripsy does not rely on heat, thereby minimizing risks associated with thermal damage. This technology is particularly effective in treating liver tumors and is being explored for other applications such as kidney and prostate cancers. The increasing prevalence of cancer worldwide is a major factor fueling the demand for advanced treatment modalities like histotripsy. Additionally, the technology’s non-invasive nature reduces recovery time and hospital stays, making it an attractive option for both patients and healthcare providers.

The global histotripsy systems market size in 2026 is witnessing rapid growth, driven by advancements in non-invasive medical technologies and increasing demand for innovative cancer treatment solutions. Histotripsy, a non-thermal focused ultrasound technique, is emerging as a revolutionary approach for tissue destruction, particularly in oncology applications.

According to Fortune Business Insights, the global histotripsy systems market size was valued at USD 63.8 million in 2025. The market is projected to grow from USD 95.7 million in 2026 to USD 592.5 million by 2034, exhibiting a remarkable CAGR of 25.6% during the forecast period.

This strong growth trajectory reflects the increasing adoption of minimally invasive procedures, rising healthcare investments, and growing awareness regarding advanced therapeutic technologies. Histotripsy systems are gaining traction due to their precision, reduced side effects, and ability to treat tumors without damaging surrounding tissues.

Market Drivers & Restraints

Drivers:

• Rising incidence of cancer and chronic diseases globally

• Growing preference for non-invasive and minimally invasive treatment options

• Technological advancements in ultrasound-based therapies

• Increasing investments in healthcare infrastructure and research

Restraints:

• Limited availability of histotripsy systems in developing regions

• High cost associated with advanced medical equipment

• Regulatory challenges and lengthy approval processes

Market Report Coverage

The histotripsy systems market report provides a comprehensive analysis of key market dynamics, including growth drivers, restraints, opportunities, and challenges. It also offers detailed insights into market segmentation, competitive landscape, and regional analysis. The report highlights recent developments, technological advancements, and strategic initiatives undertaken by leading market players.

Market Competitive Landscape

The competitive landscape of the histotripsy systems market is characterized by the presence of key players focusing on research collaborations, clinical trials, and product innovation. Companies are investing heavily in expanding their technological capabilities and strengthening their market position.

Top Companies In The Market

• HistoSonics (U.S.)

• Focused Ultrasound Foundation (U.S.)

• Regents of the University of Michigan (U.S.)

• Mayo Foundation for Medical Education and Research (U.S.)

• Cleveland Clinic (U.S.)

• Johns Hopkins University (U.S.)

• University of Oxford (U.K.)

• Imperial College London (U.K.)

These organizations are actively involved in advancing histotripsy technology through clinical research, partnerships, and innovation initiatives.

Market Segments

The histotripsy systems market can be segmented based on application, end-user, and region.

By Product Type (Instruments and Accessories)

By Technology Type (Cavitation-based Histotripsy and Boiling Histotripsy)

By Application (Liver Tumors, Kidney Tumors, Pancreatic Tumors, and Others)

By End User (Hospitals & ASCs, Specialty Clinics, and Others)

Explore the full research report with detailed insights and TOC: https://www.fortunebusinessinsights.com/histotripsy-systems-market-115706 

Market Regional Insights

Geographically, the histotripsy systems market is segmented into North America, Europe, Asia Pacific, and the rest of the world. North America holds the largest market share due to the presence of leading healthcare institutions, strong research ecosystem, and early adoption of advanced technologies.

Europe is also witnessing significant growth, supported by increasing healthcare investments and rising awareness about non-invasive treatments. Meanwhile, the Asia Pacific region is expected to grow at a rapid pace during the forecast period, driven by improving healthcare infrastructure and growing patient population.

Future Market Scope

The future of the histotripsy systems market looks promising, with continuous advancements in ultrasound technology and increasing clinical applications. Ongoing research and development activities are expected to expand the use of histotripsy beyond oncology, opening new avenues in other therapeutic areas.

Furthermore, strategic collaborations between research institutions and medical device companies are likely to accelerate innovation and commercialization of histotripsy systems. As awareness and accessibility improve, the adoption of this technology is expected to increase significantly across the globe.

Recent Industry Developments

• November 2025: Allina Health Cancer Institute care team at Abbott Northwestern Hospital has successfully performed the first histotripsy procedure in the Twin Cities, marking a significant milestone in noninvasive cancer treatment.

• June 2025: HistoSonics has announced the completion of enrollment in a pivotal trial to evaluate its histotripsy platform in treating kidney tumors. This helped the company in strengthening its presence.

Conclusion

The histotripsy systems market is poised for substantial growth in the coming years, driven by technological innovation, increasing demand for non-invasive treatments, and rising prevalence of cancer. With a strong pipeline of clinical research and growing adoption across healthcare facilities, histotripsy is set to transform the landscape of cancer treatment. Market players are focusing on expanding their capabilities and strengthening their global presence, further contributing to the market’s expansion.

As the healthcare industry continues to evolve, histotripsy systems are expected to play a crucial role in delivering effective and patient-friendly treatment solutions, making them a key component of the future medical ecosystem.

Contact us:

Fortune Business Insights™ Pvt.

Phone: USA: +1 833 909 2966 (Toll-Free),

United Kingdom: +44 808 502 0280 (Toll-Free),

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com